BMS 986187 - Moligand™, ≥98%(HPLC) , Allosteric modulator of δ receptor;Allosteric modulator of μ receptor, CAS No.684238-37-7, Allosteric modulator of δ receptor;Allosteric modulator of μ receptor

CAS: 684238-37-7 Cat. No.: B287441 Formula: C31H34O4 Molecular Weight: 470.61
AVAILABLE TO ORDER
GRADE & PURITY Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%(HPLC)
Synonyms
3,4,5,6,7,9-Hexahydro-3,3,6,6-tetramethyl-9-[4-[(2-methylphenyl)methoxy]phenyl]-1H-xanthene-1,8(2H)-dione|BMS986187|BMS-986187
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Size
Germany (EU)
USA*
Price
Qty
5mg
B287441-5mg
—
3 In stock
€130.07
10mg
B287441-10mg
—
3 In stock
€187.34
25mg
B287441-25mg
—
2 In stock
€343.54
50mg
B287441-50mg
—
2 In stock
€515.35
100mg
B287441-100mg
—
2 In stock
€867.65
Enter a quantity for the sizes you want to add.

Specifications

Synonyms
3,4,5,6,7,9-Hexahydro-3,3,6,6-tetramethyl-9-[4-[(2-methylphenyl)methoxy]phenyl]-1H-xanthene-1,8(2H)-dione | BMS986187 | BMS-986187
Specifications & Purity
Moligand™, ≥98%(HPLC)
Biochemical and Physiological Mechanisms
Potentδ-opioid receptor positive allosteric modulator (EC50= 30 nM). Exhibits 100-fold selectivity forδoverμ-opioid receptor. Enhances affinity of[Leu5]-Enkephalin,SNC 80 and TAN 67 for theδ-opioid receptor.
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Grade
Moligand™
Action Type
ALLOSTERIC MODULATOR
Mechanism of action
Allosteric modulator of δ receptor;Allosteric modulator of μ receptor
Purity
≥98%(HPLC)
Names and Identifiers
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/504768577
SMILES
CC1=CC=CC=C1COC2=CC=C(C=C2)C3C4=C(CC(CC4=O)(C)C)OC5=C3C(=O)CC(C5)(C)C
IUPAC Name
3,3,6,6-tetramethyl-9-[4-[(2-methylphenyl)methoxy]phenyl]-4,5,7,9-tetrahydro-2H-xanthene-1,8-dione
InChIKey
UEKIYVKPQNKSDI-UHFFFAOYSA-N
InChI
1S/C31H34O4/c1-19-8-6-7-9-21(19)18-34-22-12-10-20(11-13-22)27-28-23(32)14-30(2,3)16-25(28)35-26-17-31(4,5)15-24(33)29(26)27/h6-13,27H,14-18H2,1-5H3
Isomeric SMILES
CC1=CC=CC=C1COC2=CC=C(C=C2)C3C4=C(CC(CC4=O)(C)C)OC5=C3C(=O)CC(C5)(C)C
MeSH Entry Terms
BMS-986187
Molecular Weight
470.61
Reaxy-Rn
28330523
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=28330523&ln=

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassBenzenoids
ClassPhenol ethers
SubclassNot available
Intermediate Tree Nodes Not available
Direct ParentPhenol ethers
Alternative Parents Phenoxy compounds  Toluenes  Cyclohexenones  Alkyl aryl ethers  Pyrans  Vinylogous esters  Oxacyclic compounds  Organic oxides  Hydrocarbon derivatives  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Phenoxy compound - Phenol ether - Alkyl aryl ether - Cyclohexenone - Toluene - Monocyclic benzene moiety - Pyran - Vinylogous ester - Ketone - Ether - Oxacycle - Organoheterocyclic compound - Hydrocarbon derivative - Organic oxygen compound - Carbonyl group - Organooxygen compound - Organic oxide - Aromatic heteropolycyclic compound
DescriptionThis compound belongs to the class of organic compounds known as phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring.
External Descriptors Not available
3D Structure
Interactive Chemical Structure Model





Associated Targets(Human)
OPRD1 Tclin Delta-type opioid receptor (5 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
OPRM1 Tclin Mu-type opioid receptor (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mechanisms of Action
Certificates (CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

5 results found

Lot NumberCertificate TypeDateItem
K2211041K2211041Certificate of AnalysisAug 12, 2025 B287441
K2211042K2211042Certificate of AnalysisAug 12, 2025 B287441
K2211043K2211043Certificate of AnalysisAug 12, 2025 B287441
K2211044K2211044Certificate of AnalysisAug 12, 2025 B287441
K2211045K2211045Certificate of AnalysisAug 12, 2025 B287441
Chemical and Physical Properties
SolubilitySolvent:DMSO, Max Conc. mg/mL: 9.41, Max Conc. mM: 20
Molecular Weight470.600 g/mol
XLogP35.800
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count4
Rotatable Bond Count4
Exact Mass470.246 Da
Monoisotopic Mass470.246 Da
Topological Polar Surface Area52.600 Ų
Heavy Atom Count35
Formal Charge0
Complexity876.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Solution Calculators
Reviews

Customer Reviews

Application Protocols

The product listing does not include tested application protocols for this item.

  • Assay types, dilutions, positive controls, and plate formats: Not specified for this item; refer to internal SOPs or literature precedents.

If needed, request the latest CoA/Spec Sheet or consult methodological literature relevant to your assay platform before use.

Biological Roles

The current product listing does not specify a biological target, pathway, or mode of action for BMS 986187.

  • Target/mechanism: Not specified for this item; refer to primary literature or internal validation data.
  • Biological classification: Small‑molecule ligand suitable for research and screening workflows (catalog context).

General considerations for small‑molecule ligands in biological systems:

  • Binding interactions may involve protein active sites or allosteric pockets, or interactions with nucleic acids or membranes; the specific context for this compound is not provided.
  • Evaluate cellular permeability, efflux liability, and nonspecific binding empirically using orthogonal assays if cellular studies are planned.
  • Consider assay interferences (aggregate formation, fluorescence overlap, redox activity); deploy counter‑screens where relevant.

Usage boundaries:

  • Supplied strictly for research use only; not for diagnostic, therapeutic, or other clinical applications.

For definitive biological role/target information, consult the peer‑reviewed literature or request additional documentation if available (CoA/Spec Sheet).

Buffer Applications

This product is a discrete small‑molecule ligand; it is not itself a buffering agent. However, buffer selection is important for assay compatibility when dosing from DMSO stocks.

General buffer guidance for small‑molecule assays:

  • Choose buffers with good pH control in the physiologically relevant range (e.g., HEPES 20–50 mM, pH 7.2–7.5; PBS 1×, pH ~7.4) as permitted by the assay.
  • Maintain constant ionic strength to reduce variability in target binding assays.
  • Minimize nonspecific adsorption by adding 0.01–0.05% nonionic surfactant (Tween‑20 or Pluronic F‑68) if compatible.
  • Control DMSO carryover (typically ≤0.1–1% v/v final) and match DMSO percentage across all wells/conditions.

Practical tips:

  • Add compound DMSO stock slowly into vortexing buffer to avoid local supersaturation and precipitation.
  • Equilibrate solutions at assay temperature and inspect for haze/precipitate before use (brief centrifugation can help clarify).

Item‑specific buffer interactions, solubility limits, and pKa values are not provided; consult the CoA/Spec Sheet and perform small‑scale compatibility tests.

Green Alternatives

Because this item is a discrete small‑molecule ligand (not a process solvent or bulk reagent), “green alternative” considerations primarily concern the choice of solvents used to dissolve and handle the compound in assays.

Greener solvent considerations (general):

  • Prefer water‑based buffers for final assay media whenever feasible; limit DMSO to the minimal percentage compatible with solubility and assay performance.
  • If organic co‑solvents are necessary, consider bio‑derived or lower‑toxicity options when compatible with your assay (e.g., glycerol derivatives at low %), recognizing that many drug‑like ligands require DMSO for adequate solubility.

Comparison snapshot (general):

  • DMSO: excellent solvency and stability; moderate toxicity; readily recyclable in process settings but typically single‑use in HTS.
  • MeCN: volatile, flammable; less favored for storage; higher EHS burden than DMSO.
  • Ethanol: greener profile but often insufficient solvency for hydrophobic ligands.

Operational tips to reduce footprint:

  • Use small‑volume aliquots to minimize waste upon thaw.
  • Standardize low‑DMSO assay protocols (≤0.1–0.5% v/v) where signal allows.
  • Employ closed‑cap automation to reduce solvent evaporation and operator exposure.

Note: There are no item‑specific green chemistry metrics (E‑factor, PMI, life‑cycle data) available for this product.

Pharmaceutical Uses

No pharmacopeial status or excipient role is provided for this item. It is supplied strictly for research use only.

Context and limitations:

  • The product name reflects an internal discovery compound code (BMS‑ series) rather than a formulated excipient or approved active ingredient.
  • Do not use for human or veterinary applications, clinical diagnostics, or manufacturing of medicinal products.

Research/manufacturing relevance (general):

  • In preclinical research settings, such small molecules may serve as tool compounds for target validation, SAR exploration, or assay development. Any such use should be guided by internal SOPs and regulatory frameworks and does not imply suitability for pharmaceutical manufacturing.

Item‑specific regulatory/compendial information (USP/EP/JP monographs, residual solvent limits, elemental impurities) is not specified for this product; refer to the CoA/Spec Sheet if available and conduct appropriate internal quality assessments before use in any regulated laboratory workflow.

Physical Properties

Item‑specific physicochemical properties are not included in the current listing. Where relevant, consult the CoA/Spec Sheet or SDS for definitive values.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point (MP): Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling point (BP): Not typically applicable for solid, non‑volatile drug‑like ligands; specific value not provided.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet.
  • LogP/LogD: Not specified for this item; refer to CoA/Spec Sheet.
  • pKa(s): Not specified for this item; refer to CoA/Spec Sheet.
  • Refractive index: Not applicable for solid samples; not specified.

Practical handling notes (general, literature/common practice for screening ligands):

  • Prepare a concentrated DMSO stock (e.g., 10–50 mM) if the compound is hydrophobic; filter if needed (PTFE, 0.22 μm) to remove particulates.
  • For aqueous assays, serially dilute the DMSO stock into buffer, keeping final DMSO typically ≤0.1–1% v/v to minimize assay interference. Add a co‑solvent or surfactant (e.g., 0.01–0.05% Tween‑20) only if permitted by the assay.
  • Avoid repeated freeze–thaw of DMSO stocks; prepare single‑use aliquots.

All quantitative property values, if required, should be taken from the item’s CoA/Spec Sheet; do not substitute literature values without verification.

Quality and Grades
  • Grade/Purity: Moligand™ (product data)

What Moligand™ signifies (general description):

  • Aladdin’s Moligand™ designation identifies compounds curated for small‑molecule screening and ligand discovery workflows in medicinal chemistry, chemical biology, and target identification. The focus is on identity, suitability for assay stock preparation, and research‑use handling.

What is and isn’t specified for this item:

  • Confirmed: product identity (name and registry identifiers) and storage at −20°C.
  • Not specified for this item; refer to CoA/Spec Sheet: exact purity %, residual solvents, water content, metal content, stabilizers/inhibitors, assay UV profile, or chromatographic specifications.

Practical guidance for users:

  • For biophysical/biochemical screening, request the CoA and (if available) LC–MS/NMR identity data to align with your internal quality acceptance criteria.
  • If low‑UV background, metal limits, or special stabilizers are critical to your application (e.g., HTS optical assays, chemoproteomics), verify these requirements with the latest Spec Sheet/CoA prior to use.

Compliance & use:

  • Supplied strictly for research use only (product data). Not for human or veterinary use, diagnostics, or clinical applications.
Reaction and Applications

This product is offered as a screening ligand/small‑molecule probe rather than as a synthetic reagent. Consequently, classical synthetic reaction families (e.g., cross‑couplings, nucleophilic substitutions) are generally not the intended use case for this item.

  • Intended use (catalog context): discovery and screening workflows in medicinal chemistry or chemical biology (e.g., target engagement studies, phenotypic screening) — specific targets or pathways are not provided in the listing.
  • Not typically applied as: reagent, catalyst, or building block in scale chemical synthesis.

If the molecule is to be derivatized (user‑driven medicinal chemistry):

  • Confirm structural handles and functional group compatibility via the CoA/Spec Sheet before planning any transformations.
  • Establish compound stability in planned reaction media (e.g., DMSO, MeCN, mild bases) with small‑scale tests.

Assay‑oriented notes (general practice):

  • Prepare validated DMSO stocks and verify concentration by UV‑Vis or quantitative NMR where appropriate.
  • Evaluate compound interference risks (fluorescence, redox activity, PAINS filters) with orthogonal assays when feasible.

No item‑specific reaction applications are provided by the manufacturer for this listing.

Reaction Conditions

Not typically applicable. This item is supplied as a research ligand rather than a reagent for chemical transformations, and the listing does not disclose functional groups that would guide specific reaction conditions.

If user pursues custom chemistry (general considerations only):

  • Solvents: Begin with anhydrous DMSO, DMF, or MeCN for polar, drug‑like substrates; switch to less polar media as structure dictates.
  • Temperatures: Conduct room‑temperature feasibility screens, increasing cautiously while monitoring for degradation by LC–MS.
  • Bases/acids: Use mild, non‑nucleophilic bases (DIPEA, Hünig’s base) or buffered acids to preserve sensitive motifs.
  • Atmosphere: Apply inert atmosphere if redox‑sensitive moieties are suspected.

These are generalized practices only; item‑specific conditions are not provided and should be established experimentally after confirming structure.

Safety and Handling

Authoritative safety information is provided in the product SDS. The current listing does not include GHS details for this item.

  • GHS classification: Not specified for this item; refer to SDS.
  • Signal word / H‑statements / pictograms: Not specified for this item; refer to SDS.

General laboratory precautions for small‑molecule research ligands:

  • Use in a chemical fume hood; avoid inhalation of dust or aerosols.
  • Wear appropriate PPE: lab coat, safety glasses, and chemical‑resistant gloves (e.g., nitrile). Change gloves regularly and upon contamination.
  • Avoid skin/eye contact and ingestion. Wash thoroughly after handling.
  • Prevent environmental release; dispose of waste according to institutional and local regulations.

Storage/incompatibilities:

  • Storage: Store at −20°C (product data). Keep tightly closed in original container.
  • Protect from moisture and light as a prudent precaution for drug‑like organics unless otherwise specified on the CoA.
  • Avoid strong oxidizers, strong acids/bases, and reactive reducing/oxidizing agents until compatibility is known (general precaution).

First‑aid overview (consult SDS):

  • Inhalation: Move to fresh air; seek medical attention if symptoms persist.
  • Skin/eyes: Rinse with water for several minutes; remove contaminated clothing; seek medical attention if irritation persists.
  • Ingestion: Rinse mouth; seek medical attention.

Always defer to the official SDS for hazard classification, exposure limits, and spill/accident procedures.

Solvent Selection

Item‑specific solubility data are not provided. The following guidance reflects common practice for drug‑like small molecules used in screening.

  • Primary stock solvent: DMSO is typically preferred for hydrophobic ligands due to broad solvency, stability at −20°C, and assay compatibility at low percentages.
  • Secondary co‑solvents: DMF or acetonitrile can be used for intermediate stocks; ensure compatibility with assay systems.
  • Aqueous dilution: Add DMSO stock slowly into vortexing buffer to minimize precipitation. Maintain final DMSO ≤0.1–1% v/v where possible.
  • Buffers: Use assay‑appropriate buffers (e.g., HEPES, PBS) with controlled ionic strength; consider adding 0.01–0.05% nonionic surfactant if permitted to aid solubilization of hydrophobic compounds.

Comparison (general):

  • DMSO vs DMF: DMSO offers better biocompatibility in most assays; DMF may be more cytotoxic and hygroscopic.
  • DMSO vs acetonitrile: DMSO is better for long‑term frozen stocks; acetonitrile is volatile and less suitable for storage.

Tips:

  • If solubility is uncertain, start with 1–5 mM trial solutions in DMSO and evaluate clarity/crystallization at −20°C and after thaw.
  • Filter solutions through 0.22 μm PTFE if particles persist; avoid cellulose filters that may bind hydrophobic molecules.

All solvent choices should be confirmed experimentally for the specific assay context.

Storage and Reconstitution
  • Storage conditions: Store at −20°C (product data). Keep container tightly closed. For long‑term storage, consider amber vials and desiccation as general good practice for small molecules.
  • Shipping: Ice chest + ice pads (product data).

Reconstitution and stock preparation (general guidance for screening ligands):

  • Allow vial to equilibrate to room temperature in a desiccator before opening to minimize moisture condensation.
  • Prepare a concentrated DMSO stock (e.g., 10–50 mM) based on anticipated assay use. Verify complete dissolution; gentle warming (≤37°C) and vortexing/sonication may help.
  • If aqueous use is required, slowly dilute the DMSO stock into buffer with vigorous mixing to avoid precipitation. Keep final DMSO typically ≤0.1–1% v/v.
  • Prepare single‑use aliquots to avoid repeated freeze–thaw. Store aliquots at −20°C in sealed, inert‑lined caps.
  • Inspect solutions for particulates/precipitation after thaw; discard if instability is observed.

Item‑specific parameters (solubility limits, stability in various solvents, pH sensitivity) are not specified for this item; consult the CoA/Spec Sheet and perform small‑scale tests to confirm suitability for your application.

Structure and Identity

A curated small‑molecule research ligand supplied as part of Aladdin’s Moligand™ collection. Item‑specific structural identifiers are limited in the current listing.

  • Product name: BMS 986187 (research chemical; small molecule ligand)
  • CAS: 684238-37-7 (product data)
  • PubChem CID: 17379334 (product data)
  • InChIKey: 357732 (as provided; appears truncated/not in standard 14-14-1 format)
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.

Structural features (general notes):

  • Item-specific ring systems/functional groups and stereochemistry are not provided in the current product data. Please consult the CoA/Spec Sheet for definitive structure.
  • As a proprietary BMS‑coded ligand name, this compound is typically a heteroatom‑containing, drug‑like small molecule (general medicinal chemistry context), but exact features must be confirmed from primary structure data.

2D structure description:

  • Not available in this listing. If a structure file (SDF/MOL/SKetch) is required for cheminformatics workflows, request the latest specification package from Aladdin Scientific (CoA/Spec Sheet).
Synthetic Utility

This product is offered as a screening ligand/probe, not as a general synthetic building block. Without a disclosed structure, specific retrosynthetic disconnections or functional‑group transformations cannot be recommended.

General guidance if user intends derivatization:

  • Obtain the exact structure and functional map (from CoA/Spec Sheet or literature) before planning modifications.
  • Assess chemical stability (acid/base sensitivity, redox, photolability) with small‑scale tests.
  • If present, typical handles (amines, phenols, carboxylates, halides) can enable formation of amide/urea/ether linkages or cross‑couplings; conditions must be tailored to the verified structure.

Caveats:

  • Do not assume reactivity or protection strategies without confirmed functional groups.
  • Verify impurity profile and perform analytical characterization (LC–MS, NMR, HRMS) after any transformation to preserve SAR relevance.

No manufacturer‑provided information on synthetic use cases is available for this item.

Target Specificity

No target, pathway, or binding specificity is provided in the current product data for BMS 986187.

  • Target name/class: Not specified for this item; refer to literature or internal validation.
  • Species reactivity/selectivity: Not specified for this item.
  • Assay‑validated potency/affinity: Not specified for this item.

Users should consult peer‑reviewed sources or generate in‑house data to define target engagement and selectivity profiles before drawing biological conclusions.

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.